NN

Nnamdi Nwachukwu

Biotech | Health Care | Investor | Oxford & Dartmouth Alumnus

Washington, District of Columbia

Investor
VC

Invests in

Stages:

Seed
Pre-seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Quality Reviews
Privacy Policies
Building Management Systems
U.S. Health Insurance Portability and Accountability Act (HIPAA)
Industry standards
Quality Risk Management
Value Creation
Venture Capital
Performance Engineering
Concept to Launch
Software Development
Technical Leadership
Regulatory Requirements
Computer Science
Stability Studies
Immunology
Oncology
Research Methods
Market Access
Social Influence

Education

Lists including NNAMDI

AH
AL
AS
AD

Based in Seattle

494 people

AM
AT
AS
AR

All Seed Investors

19691 people

AT
AE
AE
AL

All Pre-Seed Investors

7972 people

Work Experience

RI
RRD International, LLC

2019

  • Senior Vice President, Quality & Chief Information Officer

    2019

OV
Oxonian Ventures

2021

  • Advisor - Life Sciences

    2024

  • Venture Associate - Life Sciences Investments

    2021 - 2024

AI
Altimmune, Inc.

2017 - 2019

  • Head, Regulatory Affairs and Quality Operations

    2017 - 2019

US
United States Department of Defense

2016 - 2017

  • Head, Regulatory Portfolio Advisor

    2016 - 2017

P-
PATH - Center for Vaccine Innovation & Access

2014 - 2016

  • Regulatory CMC Manager / Health Economist

    2014 - 2016

A
Amgen

2013 - 2014

  • Senior Regulatory Management Consultant

    2013 - 2014

FM
Fresenius Medical Care

2012 - 2013

  • Regulatory Affairs Engineer

    2012 - 2013

G
Genzyme

2010 - 2012

  • Quality Systems Engineer

    2010 - 2012